Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ACC 2008: Analysts keep faith with Medtronic after CRT trial misses endpoint

This article was originally published in Clinica

Executive Summary

Medtronic's REVERSE study, examining the suitability of cardiac resynchronisation therapy (CRT) in patients with mild heart failure, has missed its primary endpoint. The failure of the trial, presented at the annual meeting of the American College of Cardiology (ACC), raises questions about what constitutes appropriate pacemaker use.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel